NCT02165033View on ClinicalTrials.gov

"Multiple-dose Pharmacokinetics Study of SYN006 HFA MDI Administered Orally to Healthy Volunteers"

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

February 28, 2013

Conditions
Asthma
Interventions
DRUG

Budesonide/Procaterol 180/10 X 4 puffs

Budesonide/Procaterol 180/10mcg, 4 puffs, Repeated dose

Trial Locations (1)

114

Tri-Service General Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Intech Biopharm Ltd.

INDUSTRY

NCT02165033 - "Multiple-dose Pharmacokinetics Study of SYN006 HFA MDI Administered Orally to Healthy Volunteers" | Biotech Hunter | Biotech Hunter